Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
Clinical trial NCT00532623 · COMPLETED
Trial details
- NCT number
- NCT00532623
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-09-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.